SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-045257
Filing Date
2021-04-01
Accepted
2021-04-01 08:58:09
Documents
3
Period of Report
2021-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM-8-K tm2111564d1_8k.htm 8-K 20795
2 EXHIBIT 99.1 tm2111564d1_ex99-1.htm EX-99.1 12136
3 GRAPHIC tm2111564d1_ex99-1img01.jpg GRAPHIC 4785
  Complete submission text file 0001104659-21-045257.txt   40916
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 21796182
SIC: 2834 Pharmaceutical Preparations